How Treating Myeloma is About Extending Remissions and Making it ‘Livable’
April 12th 2021In an interview, Dr. Nina Shah of UCSF Helen Diller Family Comprehensive Cancer Center discusses how she changed her perspective on finding a cure for myeloma and what her goals are when it comes to treating her patients.
Read More
Treatments for Multiple Myeloma Are Transforming Lives
April 1st 2021The biggest fear for many patients, according to an expert from The University of Texas MD Anderson Cancer Center, is when they hear that myeloma, for most patients, is not curable. However, she notes that every few years patient survival is increasing.
Read More
Multiple Myeloma 101: An Incurable But ‘Very Treatable’ Disease
March 22nd 2021Although a multiple myeloma diagnosis can be overwhelming for patients, an expert from the Massachusetts General Hospital Cancer Center notes how the disease is very treatable, and that patients can go on to lead full lives.
Read More
Clinical Trials on Smoldering Myeloma May Open Doors to More Precision Medicine
December 29th 2020In an interview with CURE®, Dr. Irene M. Ghobrial discussed smoldering myeloma, a precursor condition that may progress to multiple myeloma, how to proceed if diagnosed with the condition and the available opportunities to participate in clinical trials to learn more.
Read More
Understanding New Treatment Options for Patients with Relapsed/Refractory Multiple Myeloma
December 15th 2020The complexity of multiple myeloma can make it difficult to treat, but with complexity comes more avenues for researchers to explore what treatments work best. Recently, CURE® spoke with an expert from Dana-Farber Cancer Institute on what patients can expect to see from the clinical setting.
Read More
Evolving Standards and Heated Debates in the Treatment of Newly Diagnosed Multiple Myeloma
December 4th 2020Evolving standards of care in newly diagnosed multiple myeloma (MM) have given patients a wider variety of possibilities but can also be disconcerting. In a presentation during CURE®’s Educated Patient® Multiple Myeloma Summit, Dr. Clifton Mo, of Dana-Farber Cancer Institute, explores the treatment landscape and breaks down what these different options can offer patients.
Read More
Understanding the Role of Immunoglobulins in Multiple Myeloma
December 16th 2019At CURE’s Educated Patient Summit on Multiple Myeloma Dr. Shebli Atrash had the chance to further discuss with CURE what questions he addresses most when patients with multiple myeloma undergo diagnostic testing.
Read More
MRD Measurement Shows Promise for Making Informed Treatment Decisions in Myeloma
December 15th 2019At CURE’s Educated Patient Summit on Multiple Myeloma, Dr. Barry Paul discussed the role of minimal residual disease measurement and how it may be used in the future to determine treatment options for patients with myeloma.
Read More